CFI-400945 Fumarate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CFI-400945 Fumarate, covering 2024-08-22 to 2024-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS [Phase 1]